Answers are grounded in this paper and cite their sources.
The meningeal lymphatic system has emerged as an important component of central nervous system fluid regulation and immune homeostasis, although its causal contribution to neurodegenerative disorders remains uncertain. This systematic review evaluated disease-specific evidence linking meningeal lymphatic function to Alzheimer's disease, Parkinson's disease, and aging-associated neuroimmune alterations. A structured literature search was conducted in PubMed, supplemented by publisher records and backward reference screening, to identify peer-reviewed English-language studies published between January 1, 2015, and October 7, 2026, that investigated meningeal or dural lymphatic structure and function in mammalian models or humans. Primary experimental studies and human imaging investigations were prioritized. Findings were synthesized narratively across three predefined domains because heterogeneity in experimental models, tracer systems, and outcome measures precluded quantitative meta-analysis. Experimental evidence suggested that impaired meningeal lymphatic drainage contributed to increased extracellular tau retention, alterations in selected amyloid-beta (Aβ) pathology measures, exacerbated alpha-synuclein (α-synuclein) pathology, heightened neuroinflammation, accumulation of senescent astrocytes, and oligodendrocyte loss. Human imaging studies also indicated reduced meningeal lymphatic drainage in patients with idiopathic Parkinson's disease. However, sustained meningeal lymphatic atrophy or expansion did not significantly alter overall amyloid plaque burden in two mouse models of Alzheimer's disease, suggesting potential compensatory clearance mechanisms and pathway-dependent effects. Collectively, these findings supported the interpretation that meningeal lymphatic vessels function as a potentially modifiable component of an interconnected cerebral clearance and neuroimmune regulatory network rather than as the sole rate-limiting determinant of pathological protein accumulation. Clinical translation will require standardized human lymphatic imaging protocols, longitudinal validation of disease-relevant biomarkers, and patient stratification according to disease stage to determine when impaired meningeal lymphatic drainage represents a therapeutically relevant limitation.
No takes yet. Share an insight, caveat, or question.
Komang Trisna Sumadewi (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: